Physician profile
Joey Gee
NPI 1710058698
$10,909.74
in general payments reported to CMS, 2019-2025
58 companies · $1,519 in 2025
The $1,519 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $1,356 · 2021: $1,627 · 2022: $1,094 · 2023: $1,687 · 2024: $2,895 · 2025: $1,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,739 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,738.81 |
| Education | $361.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,340.11 | 2021-2025 | |
| Allergan, INC. | $996.47 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $780.63 | 2019-2025 | Nuplazid, Daybue |
| Alexion Pharmaceuticals, INC. | $675.10 | 2023-2025 | Ultomiris |
| Biogen, INC. | $648.27 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Teva Pharmaceuticals USA, INC. | $622.17 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Supernus Pharmaceuticals, INC. | $455.73 | 2019-2021 | |
| Sk Life Science, INC. | $432.00 | 2020-2024 | |
| Pfizer INC. | $290.66 | 2023-2025 | |
| Mdd US Operations, LLC | $269.52 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Ucb, INC. | $253.56 | 2019-2025 | Briviact, Zilbrysq |
| Lilly USA, LLC | $211.28 | 2019-2024 | Emgality, Amyvid, Reyvow |
| Biohaven Pharmaceuticals, INC. | $179.49 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $177.97 | 2019-2024 | |
| Lundbeck LLC | $171.14 | 2022-2025 | Vyepti, Rexulti |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Gee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.